Brainstorm announces scientific presentation of nurown® exosome preclinical ards data at nyscf 2021 virtual meeting

New york, oct. 18, 2021 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced the presentation today of a poster titled, "therapeutic benefits of msc-ntf (nurown®) exosomes in acute lung injury models" at the nyscf 2021 virtual meeting, being held on october 19-20, 2021.  the poster will be presented tomorrow, october 19, at 3:45 – 5:00pm eastern time.
BCLI Ratings Summary
BCLI Quant Ranking